secwatch.observer — SEC 8-K summary
======================================

Issuer:     60 DEGREES PHARMACEUTICALS, INC. (SXTP)
CIK:        0001946563
Form:       8-K
Filed at:   2024-02-02T23:59:59+00:00
Accession:  0001575872-24-000114
Event type: other_material
Sentiment:  neutral
Materiality: 0.60
Item codes: 8.01, 1.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

60 Degrees Pharmaceuticals closes $2.4M public offering of units and pre-funded units
--------------------------------------------------------------------------------

- Gross proceeds ~$2.4M; net proceeds ~$1.9M after underwriter discounts and expenses.
- Offering included 5,260,901 units at $0.385/unit and 999,076 pre-funded units at $0.375/unit.
- Each unit consists of one share of common stock and one warrant (exercise price $0.4235, 5-year term).
- Underwriters partially exercised over-allotment for 818,177 warrants.
- Net proceeds to fund working capital, relaunch of ARAKODA malaria prevention, and R&D.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1946563/000157587224000114/0001575872-24-000114-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1946563/000157587224000114/sxtp-20240129.htm
  HTML page:      https://secwatch.observer/filing/0001575872-24-000114

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer